Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 206,142,100 papers from all fields of science
Search
Sign In
Create Free Account
Effector T-Lymphocyte
Known as:
Effector T Lymphocyte
, Effector T Cells
, Effector T Cell
Expand
A mature T-lymphocyte that has differentiated into a form that can mount an antigen-specific immune response.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Hematopoietic and Lymphoid Tissue
Lymphoid Tissue
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
Nataly Manjarrez-Orduño
,
L. Menard
,
+15 authors
S. Nadler
Front. Immunol.
2018
Corpus ID: 51906311
Agents targeting the PD1–PDL1 axis have transformed cancer therapy. Factors that influence clinical response to PD1–PDL1…
Expand
Review
2017
Review
2017
Dietary proanthocyanidins prevent ultraviolet radiation-induced non-melanoma skin cancer through enhanced repair of damaged DNA-dependent activation of immune sensitivity.
S. Katiyar
,
H. Pal
,
R. Prasad
Seminars in cancer biology
2017
Corpus ID: 3426433
2017
2017
Curtailed T‐cell activation curbs effector differentiation and generates CD8+ T cells with a naturally‐occurring memory stem cell phenotype
V. Zanon
,
K. Pilipow
,
+8 authors
E. Lugli
European journal of immunology
2017
Corpus ID: 10769234
Human T memory stem (TSCM) cells with superior persistence capacity and effector functions are emerging as important players in…
Expand
2016
2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice
Esilida Sula Karreci
,
Hao Fan
,
+16 authors
J. Azzi
Proceedings of the National Academy of Sciences
2016
Corpus ID: 4821916
Significance The potential of proteasome inhibitors to prevent transplant rejection and to treat other immune disorders is…
Expand
2015
2015
Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
M. Bulatović Ćalasan
,
S. Vastert
,
+5 authors
F. van Wijk
Rheumatology
2015
Corpus ID: 10630429
OBJECTIVE The balance between Treg and effector T cells (Teff) is crucial for immune regulation in JIA. How MTX, the cornerstone…
Expand
Review
2014
Review
2014
Pathophysiology of JIA-associated Uveitis
S. Vastert
,
P. Bhat
,
D. Goldstein
Ocular immunology and inflammation
2014
Corpus ID: 207486480
Abstract Juvenile idiopathic arthritis (JIA)-associated uveitis is an intriguing manifestation of JIA and an important…
Expand
Review
2013
Review
2013
Tissue Specific Heterogeneity in Effector Immune Cell Response
Saba Tufail
,
Khan Farheen Badrealam
,
A. Sherwani
,
U. D. Gupta
,
M. Owais
Front. Immunol.
2013
Corpus ID: 2705252
Post pathogen invasion, migration of effector T-cell subsets to specific tissue locations is of prime importance for generation…
Expand
2012
2012
Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma.
Magali Grange
,
M. Buferne
,
G. Verdeil
,
L. Leserman
,
A. Schmitt‐Verhulst
,
N. Auphan-Anezin
Cancer research
2012
Corpus ID: 6474615
Immunotherapy based on adoptive transfer of tumor antigen-specific CD8(+) T cell (TC) is generally limited by poor in vivo…
Expand
Review
2003
Review
2003
Experimental autoimmune encephalomyelitis: Cytokines, effector t cells, and antigen-presenting cells in a prototypical th1-mediated autoimmune disease
B. Segal
Current allergy and asthma reports
2003
Corpus ID: 42691203
Experimental autoimmune encephalomyelitis (EAE) is widely depicted as the prototypical CD4+ Th1-mediated autoimmune disease…
Expand
Highly Cited
1998
Highly Cited
1998
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.
K. Flynn
,
G. Belz
,
J. Altman
,
R. Ahmed
,
D. Woodland
,
P. Doherty
Immunity
1998
Corpus ID: 41764093
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE